Salesforce

Measure Paper - CMS 2022 Measure 136v11 for NextGen Office

« Go Back

Information

 
Application Version
Program/Measure YearMIPS 2022
Build Version
Document Summary
DomainEffective Clinical Care
Measure NameFollow-Up Care for Children Prescribed ADHD Medication (ADD)
DescriptionPercentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported.  
  • Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-day Initiation Phase.
  • Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.
Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
KeywordseCQM CMS136 "attention-deficit/hyperactivity disorder" ADHD medications meds drugs children ADD MIPS
TitleMeasure Paper - CMS 2022 Measure 136v11 for NextGen Office
URL NameCMS136

Powered by